Indeed, our group has reported Spinocerebellar Ataxia (SCA3) (Jansen-West et al., 2022) and Tau (Cook et al., 2015) models which could be combined with knockdown of disease modifiers in our CRISPRi mouse. The gene discussed is MAPT; the disease is cerebellar ataxia.